Oncology drugs · Anti-infective drugs · Clinical development
Qurient
A biotech developing cancer and infectious-disease drugs, advancing its own discovered candidates through clinical stages. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Pharmaceuticals & Biotechnology · Biopharma & Life Sciences · primary Oncology & ADCs · Biopharma & Life Sciences
Other companies in the same category
- Pharmaceuticals & Biotechnology: Alnylam Pharmaceuticals · Regeneron Pharmaceuticals · Moderna · AbbVie · Lilly (Eli)
- Oncology & ADCs: Bristol-Myers Squibb Company · Merck & Co. · LigaChem Biosciences · Daiichi Sankyo · HLB
115180.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-10-08'21-5.8%'22-67.6%'23-36%'24+18.6%'25+591.9%YTD-34.7%
Money in ▸·
Qurient
▸ Money out·
Financials & Segments
- Segments · Drug development (oncology/infection)
Revenue from
No refined links yet.
Pays to
No refined links yet.